Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Wyeth-Ayerst seeks European approval of Rapamune

Feb. 18, 1999

Good safety, increased immunogenicity reported for MF59-adjuvanted flu vaccine

Feb. 12, 1999

ID Biomedical and Ribi ImmunoChem to develop E. coli vaccine

Feb. 11, 1999

DTaP-IPV vaccine receives marketing authorization in Germany

Feb. 11, 1999

Adjuvants and immunoeffectors from AGP series under evaluation at Ribi

Feb. 9, 1999

NIH seeks licensees and/or CRADA partners for development of HCV vaccine

Feb. 9, 1999

Novartis describes new PNP inhibitor series in recent patent literature

Feb. 8, 1999

Novel ferrioxamine immunosuppressant discovered at Japanese research institutes

Feb. 5, 1999

Abgenix reports positive preliminary results from phase II trial of GVHD treatment

Feb. 5, 1999

EMEA marketing approval for Triacelluvax

Feb. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 16, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...